Your browser doesn't support javascript.
loading
Arsenic trioxide therapy predisposes to herpes zoster reactivation despite minimally myelosuppressive therapy.
Glass, Jacob L; Derkach, Andriy; Hilden, Patrick; King, Amber; Seo, Susan K; Ahr, Katya; Kishtagari, Ashwin; Levine, Ross L; Tallman, Martin S; Douer, Dan.
Affiliation
  • Glass JL; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, United States. Electronic address: glassj@mskcc.org.
  • Derkach A; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, United States.
  • Hilden P; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, United States.
  • King A; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, United States.
  • Seo SK; Department of Medicine, Infectious Disease Service, Memorial Sloan Kettering Cancer Center, United States.
  • Ahr K; Lewis Katz School of Medicine, Temple University, United States.
  • Kishtagari A; Department of Medicine, Mount Sinai St. Luke's West Hospital, United States.
  • Levine RL; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, United States.
  • Tallman MS; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, United States. Electronic address: tallmanm@mskcc.org.
  • Douer D; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, United States. Electronic address: douer_d@med.usc.edu.
Leuk Res ; 106: 106569, 2021 07.
Article in En | MEDLINE | ID: mdl-33857746

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Virus Activation / Herpesvirus 3, Human / Arsenic Trioxide / Herpes Zoster / Antineoplastic Agents Type of study: Diagnostic_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Leuk Res Year: 2021 Document type: Article Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Virus Activation / Herpesvirus 3, Human / Arsenic Trioxide / Herpes Zoster / Antineoplastic Agents Type of study: Diagnostic_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Leuk Res Year: 2021 Document type: Article Country of publication: United kingdom